Compounds > erlotinib
Page last updated: 2024-09-05

erlotinib and Pancreatic Neoplasms

erlotinib has been researched along with Pancreatic Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bhattacharya, R; Bovonratwet, P; Liu, L; Mathew, MP; Saeui, CT; Tan, E; Yarema, KJ1
Furukawa, K; Hasegawa, T; Kojima, H; Mukaida, N; Nagano, T; Nakano, H; Okabe, T; Saito, N1
Augustin, E; Borowa-Mazgaj, B; Horowska, B; Konopa, J; Mazerska, Z; Paluszkiewicz, E; Paradziej-Łukowicz, J; Peszyńska-Sularz, G1

Other Studies

3 other study(ies) available for erlotinib and Pancreatic Neoplasms

ArticleYear
Metabolic glycoengineering sensitizes drug-resistant pancreatic cancer cells to tyrosine kinase inhibitors erlotinib and gefitinib.
    Bioorganic & medicinal chemistry letters, 2015, Mar-15, Volume: 25, Issue:6

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Glycosylation; Humans; Metabolic Engineering; Pancreatic Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Quinazolines; STAT Transcription Factors

2015
Design and synthesis of an in vivo-efficacious PIM3 kinase inhibitor as a candidate anti-pancreatic cancer agent.
    Bioorganic & medicinal chemistry letters, 2015, Dec-15, Volume: 25, Issue:24

    Topics: Animals; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Drug Design; Humans; Inhibitory Concentration 50; Mice; Mice, Nude; Molecular Dynamics Simulation; Pancreatic Neoplasms; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Proto-Oncogene Proteins; Structure-Activity Relationship; Transplantation, Heterologous

2015
Design, synthesis and high antitumor potential of new unsymmetrical bisacridine derivatives towards human solid tumors, specifically pancreatic cancers and their unique ability to stabilize DNA G-quadruplexes.
    European journal of medicinal chemistry, 2020, Oct-15, Volume: 204

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry Techniques, Synthetic; DNA; Drug Design; Drug Screening Assays, Antitumor; G-Quadruplexes; Humans; Mice; Pancreatic Neoplasms; Structure-Activity Relationship

2020